Viewing StudyNCT00245362



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00245362
Status: COMPLETED
Last Update Posted: 2005-10-28
First Post: 2005-10-27

Brief Title: A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer
Sponsor: Cell Genesys
Organization: Cell Genesys

Conditions & Keywords Data

Conditions:
Name
Nonresectable Pancreatic Cancer
Metastatic Pancreatic Cancer
Keywords:
Name View
immunotherapy View
cancer vaccine View
pancreatic cancer View
metastatic pancreatic cancer View
unresectable pancreatic cancer View